Cargando…
First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment
This first-time-in-human (FTIH) study evaluated the safety, tolerability, pharmacokinetics, and food effect of single and repeat oral doses of GSK3036656, a leucyl-tRNA synthetase inhibitor. In part A, GSK3036656 single doses of 5 mg (fed and fasted), 15 mg, and 25 mg and placebo were administered....
Autores principales: | Tenero, David, Derimanov, Geo, Carlton, Alex, Tonkyn, John, Davies, Matt, Cozens, Simon, Gresham, Stephanie, Gaudion, Alison, Puri, Adeep, Muliaditan, Morris, Rullas-Trincado, Joaquin, Mendoza-Losana, Alfonso, Skingsley, Andrew, Barros-Aguirre, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658769/ https://www.ncbi.nlm.nih.gov/pubmed/31182528 http://dx.doi.org/10.1128/AAC.00240-19 |
Ejemplares similares
-
A Leucyl-tRNA Synthetase Urzyme: Authenticity of tRNA Synthetase Catalytic Activities and Promiscuous Phosphorylation of Leucyl-5′AMP
por: Hobson, Jessica J., et al.
Publicado: (2022) -
A human leucyl-tRNA synthetase as an anticancer target
por: Gao, Guangwei, et al.
Publicado: (2015) -
Ancient origin of the divergent forms of leucyl-tRNA synthetases in the Halobacteriales
por: Andam, Cheryl P, et al.
Publicado: (2012) -
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
por: Palencia, Andrés, et al.
Publicado: (2016) -
Leucyl-tRNA synthetase deficiency systemically induces excessive autophagy in zebrafish
por: Inoue, Masanori, et al.
Publicado: (2021)